Eagle Rock Investment Company, LLC Corcept Therapeutics Inc Transaction History
Eagle Rock Investment Company, LLC
- $616 Million
- Q2 2025
A detailed history of Eagle Rock Investment Company, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Eagle Rock Investment Company, LLC holds 4,000 shares of CORT stock, worth $294,360. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,000
Previous 3,000
33.33%
Holding current value
$294,360
Previous $163,000
79.75%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
463Shares Held
82.7MCall Options Held
452KPut Options Held
947K-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$712 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$568 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$461 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...